Registered number
11930808
Pharmahealth (Midlands) Limited
Filleted Accounts
30 April 2024
Pharmahealth (Midlands) Limited
Registered number: 11930808
Balance Sheet
as at 30 April 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 574,474 576,553
574,474 576,553
Current assets
Stocks 48,250 50,229
Debtors 4 297,308 248,100
Cash at bank and in hand 66,771 100,474
412,329 398,803
Creditors: amounts falling due within one year 5 (108,023) (64,064)
Net current assets 304,306 334,739
Total assets less current liabilities 878,780 911,292
Creditors: amounts falling due after more than one year 6 (336,281) (436,166)
Net assets 542,499 475,126
Capital and reserves
Called up share capital 100 100
Profit and loss account 542,399 475,026
Shareholders' funds 542,499 475,126
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Tharanum Asghar
Director
Approved by the board on 5 March 2025
Pharmahealth (Midlands) Limited
Notes to the Accounts
for the year ended 30 April 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 9 13
3 Tangible fixed assets
Land and buildings Plant and machinery etc Motor vehicles Total
£ £ £ £
Cost
At 1 May 2023 562,500 25,500 7,048 595,048
Additions - 915 - 915
At 30 April 2024 562,500 26,415 7,048 595,963
Depreciation
At 1 May 2023 - 15,055 3,440 18,495
Charge for the year - 2,272 722 2,994
At 30 April 2024 - 17,327 4,162 21,489
Net book value
At 30 April 2024 562,500 9,088 2,886 574,474
At 30 April 2023 562,500 10,445 3,608 576,553
4 Debtors 2024 2023
£ £
Trade debtors 247,039 223,284
Other debtors 50,269 24,816
297,308 248,100
5 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 37,423 31,464
Other creditors 70,600 32,600
108,023 64,064
6 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 336,281 436,166
336,281 436,166
Pharmahealth (Midlands) Limited 11930808 false 2023-05-01 2024-04-30 2024-04-30 VT Final Accounts April 2024 Tharanum Asghar No description of principal activity 11930808 2022-05-01 2023-04-30 11930808 core:WithinOneYear 2023-04-30 11930808 core:AfterOneYear 2023-04-30 11930808 core:ShareCapital 2023-04-30 11930808 core:RetainedEarningsAccumulatedLosses 2023-04-30 11930808 2023-05-01 2024-04-30 11930808 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11930808 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 11930808 bus:Director40 2023-05-01 2024-04-30 11930808 1 2023-05-01 2024-04-30 11930808 2 2023-05-01 2024-04-30 11930808 core:LandBuildings 2023-05-01 2024-04-30 11930808 core:PlantMachinery 2023-05-01 2024-04-30 11930808 core:Vehicles 2023-05-01 2024-04-30 11930808 bus:FRS102 2023-05-01 2024-04-30 11930808 bus:FilletedAccounts 2023-05-01 2024-04-30 11930808 2024-04-30 11930808 core:WithinOneYear 2024-04-30 11930808 core:AfterOneYear 2024-04-30 11930808 core:ShareCapital 2024-04-30 11930808 core:RetainedEarningsAccumulatedLosses 2024-04-30 11930808 core:LandBuildings 2024-04-30 11930808 core:PlantMachinery 2024-04-30 11930808 core:Vehicles 2024-04-30 11930808 2023-04-30 11930808 core:LandBuildings 2023-04-30 11930808 core:PlantMachinery 2023-04-30 11930808 core:Vehicles 2023-04-30 iso4217:GBP xbrli:pure